Next week, members will receive a survey aimed at gathering insights on the effectiveness of the Chronic Wound Consumables Scheme (CWCS) and the challenges faced in delivering wound care. Since its introduction in May 2025, the $47.8 million scheme has provided subsidized wound consumables, removing financial barriers to accessing evidence-based treatment for eligible patients.
The Australian Medical Association (AMA) has been a strong advocate for this program, calling it an “excellent step forward” to ensure that Australians suffering from chronic wounds can receive necessary care. A report titled Solutions to the Chronic Wound Problem in Australia highlights the significant health and economic impact of chronic wounds, which affect approximately 450,000 Australians at any given time.
The CWCS specifically supports individuals suffering from chronic wounds due to diabetes, with eligibility criteria set at age 65 and over for the general population and 50 and over for First Nations people. Health professionals interested in participating in the scheme must complete designated training to qualify for involvement.
Feedback gathered from the upcoming survey will be crucial in assessing the scheme’s performance and identifying areas for improvement. The AMA encourages all members to share their experiences and insights, which will help inform future policy decisions and enhance the delivery of wound care services across Australia.
As the CWCS continues to develop, it aims to create a more accessible healthcare environment for those affected by chronic wounds, ensuring that necessary resources are available to facilitate effective treatment.
